Role of the mTORC1 complex in satellite cell activation by RNA induced mitochondrial restoration: Dual control of cyclin D1 through microRNAs

Molecular and Cellular Biology

Volumn 34, Issue 19, 2014, Pages 3594-3606

  Jash, Sukanta ^a,b   Dhar, Gunjan ^a   Ghosh, Utpalendu ^a   Adhya, Samit ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; CELL PROTEIN; CRTC2 PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 26A; RAPTOR PROTEIN; UNCLASSIFIED DRUG; CRTC2 PROTEIN, RAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MIRN1 MICRORNA, RAT; MIRN26 MICRORNA, RAT; RNA; RNA, MITOCHONDRIAL; TARGET OF RAPAMYCIN KINASE; TRANSACTIVATOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL REGENERATION; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; GENE TARGETING; MALE; MITOCHONDRION; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; RAT; SATELLITE CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INJURY; METABOLISM; PHYSIOLOGY; RNA STABILITY; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; SPRAGUE DAWLEY RAT; STEM CELL;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIN D1; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICRORNAS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RNA; RNA STABILITY; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELLS; TOR SERINE-THREONINE KINASES; TRANS-ACTIVATORS;

EID: 84906952850     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00742-14     Document Type: Article

References (41)

1. Le Grand F, Rudnicki MA. 2007. Skeletal muscle satellite cells and adult myogenesis. Curr. Opin. Cell Biol. 19:628-633. http://dx.doi.org/10.1016 /j.ceb.2007.09.012.
2. Blais A, Tsikitis M, Acosta-Alvear D, Sharan R, Kluger Y, Dynlach BD. 2005. An initial blueprint for myogenic differentiation. Genes Dev. 19: 553-569. http://dx.doi.org/10.1101/gad.1281105.
3. Brack AS, Conboy IM, Conboy MJ, Shen J, Rando TA. 2008. A temporal switch from Notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2:50-59. http://dx.doi.org/10 .1016/j.stem.2007.10.006.
4. Jash S, Adhya S. 2012. Induction of muscle regeneration by RNAmediated mitochondrial restoration. FASEB J. 26:4187-4197. http://dx .doi.org/10.1096/fj.11-203232.
5. Vasyutina E, Lenhard DC, Birchmeier C. 2007. Notch function in myogenesis. Cell Cycle 6:1451-1454. http://dx.doi.org/10.4161/cc.6.12.4372.
6. Duguez S, Fe´asson L, Denis C, Freyssenet D. 2002. Mitochondrial biogenesis during skeletal muscle regeneration. Am. J. Physiol. Endocrinol. Metab. 282:E802-E809.
7. Dennis PB, Jaeschke A, Saitoh M, Fowler B, Kozma SC, Thomas G. 2001. Mammalian TOR: a homeostatic ATP sensor. Science 294:1102- 1105. http://dx.doi.org/10.1126/science.1063518.
8. Oakhill JS, Steel R, Chen Z-P, Scott JW, Ling N, Tam S, Kemp BE. 2011. AMPK is a direct adenylate charge-regulated protein kinase. Science 332: 1433-1435. http://dx.doi.org/10.1126/science.1200094.
9. Sanchez AMJ, Candau RB, Csibi A, Pagano AF, Raibon A, Bernardi H. 2012. The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis. Am. J. Physiol. Cell Physiol. 303:C475-C485. http://dx.doi.org/10.1152/ajpcell.00125.2012.
10. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. 2002. A protein kinase B-dependent and rapamycin sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. U. S. A. 99:9213-9218. http://dx.doi.org/10.1073/pnas .142166599.
11. Ge Y, Wu AL, Warnes C, Liu J, Zhang C, Kawasome H, Terada N, Boppart MD, Schoenherr CJ, Chen J. 2009. mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinaseindependent mechanisms. Am. J. Physiol. Cell Physiol. 297:C1434 - C1444. http://dx.doi.org/10.1152/ajpcell.00248.2009.
12. Risson V, Mazelin L, Roceri M, Sanchez H, Moncollin V, Corneloup C, Richard-Bulteau H, Vignaud A, Baas D, Defour A, Freyssenet D, Tanti JF, Le-Marchand-Brustel Y, Ferrier B, Conjard-Duplany A, Romanino K, Bauche´ S, Hantai¨ D, Mueller M, Kozma SC, Thomas G, Ru¨egg MA, Ferry A, Pende M, Bigard X, Koulmann N, Schaeffer L, Gangloff YG. 2009. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 187:859-874. http://dx.doi .org/10.1083/jcb.200903131.
13. Bentzinger CF, Romanino K, Cloe¨tta D, Lin S, Mascarenhas JB, Oliveri F, Xia J, Casanova E, Costa CF, Brink M, Zorzato F, Hall MN, Ru¨egg MA. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8:411-424. http://dx.doi.org/10.1016/j.cmet.2008.10.002.
14. Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, Sonenberg N, Kelly PA, Sotiropoulos A, Pende M. 2005. Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol. 7:286-294. http://dx.doi.org/10.1038 /ncb1231.
15. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653-6662. http://dx.doi.org /10.1074/jbc.272.10.6653.
16. Cuenda A, Cohen P. 1999. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274:4341-4346. http://dx.doi.org/10.1074/jbc.274.7.4341.
17. Erbay E, Chen J. 2001. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J. Biol. Chem. 276:36079-36082. http://dx.doi.org/10.1074/jbc.C100406200.
18. Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J. 2003. IGF-II transcription in skeletal myogenesis is controlled bymTORand nutrients. J. Cell Biol. 163:931-936. http://dx.doi.org/10.1083/jcb.200307158.
19. Ge Y, Yoon MS, Chen J. 2011. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1). J. Biol. Chem. 286:35675-35682. http://dx.doi.org/10.1074/jbc .M111.262881.
20. Jaafar R, Zeiller C, Pirola L, Di Grazia A, Naro F, Vidal H, Lefai E, Ne´moz G. 2011. Phospholipase D regulates myogenic differentiation through the activation of both mTORC1 and mTORC2 complexes. J. Biol. Chem. 286:22609-22621. http://dx.doi.org/10.1074/jbc.M110.203885.
21. Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149:274-293. http://dx.doi.org/10.1016/j.cell.2012.03.017.
22. Sun Y, Ge Y, Drnevich J, Zhao Y, Band M, Chen J. 2010. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J. Cell Biol. 189:1157-1169. http://dx.doi.org/10.1083/jcb .200912093.
23. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FI, Wang D-Z. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38: 228-233. http://dx.doi.org/10.1038/ng1725.
24. Dey BK, Gagan J, Yan Z, Dutta A. 2012. miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev. 26:2180- 2191. http://dx.doi.org/10.1101/gad.198085.112.
25. Goljanek-Whysall K, Pais H, Rathjen T, Sweetman D, Dalmay T, Munsterberg A. 2012. Regulation of multiple target genes by miR-1 and miR-206 is pivotal for C2C12 myoblast differentiation. J. Cell Sci. 125: 3590-3600. http://dx.doi.org/10.1242/jcs.101758.
26. Mukherjee S, Mahata B, Mahato B, Adhya S. 2008. Targeted mRNA degradation by complex-mediated delivery of antisense RNAs to intracellular human mitochondria. Hum. Mol. Genet. 17:1292-1298. http://dx.doi.org/10.1093/hmg/ddn017.
27. Ritchie W, Rasko JEJ. 2014. Refining microRNA target predictions: sorting the wheat from the chaff. Biochem. Biophys. Res. Commun. 445:780- 784. http://dx.doi.org/10.1016/j.bbrc.2014.01.181.
28. Kitazawa S, Kitazawa R, Maeda S. 1999. Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region. J. Biol. Chem. 274:28787-28793. http://dx.doi.org/10.1074/jbc.274.40.28787.
29. Hardie DG. 2011. AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function. Genes Dev. 25:1895-1908. http://dx .doi.org/10.1101/gad.17420111.
30. Koo S-H, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussour F, Brindle P, Takemori H, Montminy M. 2005. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437:1109-1114. http://dx.doi.org/10.1038/nature03967.
31. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. 2008. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30:214-226. http://dx.doi.org /10.1016/j.molcel.2008.03.003.
32. Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR mediated translational control. Nat. Rev. Mol. Cell Biol. 10:307-318. http://dx.doi.org/10 .1038/nrm2672.
33. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13:1422-1437. http://dx.doi.org/10.1101/gad.13.11.1422.
34. Abmayr SM, Pavlath GK. 2012. Myoblast fusion: lessons from flies and mice. Development 139:641-656. http://dx.doi.org/10.1242/dev.068353.
35. Charge´ SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84:209-238. http://dx.doi.org/10.1152 /physrev.00019.2003.
36. Harrington LS, Findlay GM, Lamb RF. 2005. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem. Sci. 30:35-42. http://dx.doi.org/10.1016/j.tibs.2004.11.003.
37. Magnuson B, Ekim B, Fingar DC. 2012. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem. J. 441:1-21. http://dx.doi.org/10.1042/BJ20110892.
38. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485:109 -113. http://dx.doi.org/10.1038 /nature11083.
39. Dowling RJO, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, Petroulakis E, Wang X, Larsson O, Selvaraj A, Liu Y, Kozma SC, Thomas G, Sonenberg N. 2010. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328:1172-1176. http://dx.doi .org/10.1126/science.1187532.
40. Averous J, Fonseca BD, Proud CG. 2008. Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4Ebinding protein 1. Oncogene 27:1106-1113. http://dx.doi.org/10.1038/sj .onc.1210715.
41. Huntzinger E, Izaurralde E. 2011. Gene silencing by microRNAs: contributions of translational depression and mRNA decay. Nat. Rev. Genet. 12:99-110. http://dx.doi.org/10.1038/nrg2936.